pharma · Diarrhea-predominant Irritable Bowel Syndrome
Chengdu University of
Chengdu University of Traditional Chinese Medicine
Chengdu University of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Diarrhea-predominant Irritable Bowel Syndrome. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), an
CN HQ
256 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 256
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Loperamide
Phase 3 · small molecule · Diarrhea-predominant Irritable Bowel Syndrome
Loperamide for Diarrhea-predominant Irritable Bowel Syndrome is a Phase 3 program (small_molecule) at Chengdu University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).
Internal code 2011CB5200-Fd
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chengdu University of Traditional Chinese Medicine
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Diarrhea-predominant Irritable Bowel Syndrome
- Status
- completed
- Trials
- 1